Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 4, 2008, Pages 1645-1651

  Kowluru, Renu A ^a   Menon, Bindu ^a   Gierhart, Dennis L ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b Zeavision   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; VASCULOTROPIN; ZEAXANTHIN; 3 NITROTYROSINE; 3-NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; 8-HYDROXY-2'-DEOXYGUANOSINE; DEOXYGUANOSINE; DRUG DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NOS2 PROTEIN, RAT; SUPEROXIDE DISMUTASE; TYROSINE; UBIQUINOL CYTOCHROME C REDUCTASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A; XANTHOPHYLL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIET SUPPLEMENTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RETINA; ANIMAL; DIET; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENETICS; GLUCOSE BLOOD LEVEL; LEWIS RAT; MALE; METABOLISM;

ANIMALS; BLOOD GLUCOSE; DEOXYGUANOSINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DIET; ELECTRON TRANSPORT COMPLEX III; INTERCELLULAR ADHESION MOLECULE-1; MALE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RATS; RATS, INBRED LEW; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TYROSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XANTHOPHYLLS;

EID: 45549104909     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-0764     Document Type: Article

References (47)

1. Engerman RL, Kern TS. Hyperglycemia as a cause of diabetic retinopathy. Metabolism. 1986;35(suppl 1):20-23.
2. Baynes JW, Thrope SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999;48:1-9.
3. Kowluru RA, Tang J, Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes. 2001;50:1938-1942.
4. Haskins K, Bradley B, Powers K, et al. Oxidative stress in type 1 diabetes. Ann NY Acad Sci. 2003;1005:43-54.
5. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54:1615-1625.
6. Heath H, Rutter AC, Beck TC. Changes in the ascorbic acid and glutathione content of the retinae and adrenals from alloxan- diabetic rats. Vision Res. 1962;2:431-437.
7. Kanwar M, Chan PS, Kern TS, Kowluru RA. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by super- oxide dismutase. Invest Ophthalmol Vis Sci. 2007;48:3805-3811.
8. Kowluru RA, Odenbach S. Effect of long-term administration of alpha lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes. 2004;53:3233-3238.
9. Aiello LP, Wong JS. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int. 2000;77:S113-S119.
10. Joussen AM, Poulaki V, Le ML, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18:1450-1452.
11. Thomson LR, Toyoda Y, Langner A, et al. Elevated retinal zeaxan-thin and prevention of light-induced photoreceptor cell death in quail. Invest Ophthalmol Vis Sci. 2002;43:3538-3549.
12. Thomson LR, Toyoda Y, Delori FC, et al. Long term dietary supplementation with zeaxanthin reduces photoreceptor death in light-damaged Japanese quail. Exp Eye Res. 2002;75:529-542.
13. Stahl W, Sies H. Bioactivity and protective effects of natural caro-tenoids. Biochim Biophys Acta. 2004;1740:101-107.
14. Whitehead AJ, Mares JA, Danis RP. Macular pigment: a review of current knowledge. Arch Ophthalmol. 2006;124:1038-1045.
15. Krinsky NI, Johnson EJ. Carotenoid actions and their relation to health and disease. Mol Aspects Med. 2005;26:459-516.
16. Parekh N, Chappell RJ, Millen AE, Albert DM, Mares JA. Association between vitamin D and age-related macular degeneration in the Third National Health and Nutrition Examination Survey, 1988 through 1994. Arch Ophthalmol. 2007;125:661- 669.
17. Hozawa A, Jacobs DR, Steffes MW, Gross MA, Steffen LM, Lee DH. Relationships of circulating carotenoid concentrations with several markers of inflammation, oxidative stress, and endothelial dysfunction: the coronary artery risk development in young adults (CARDIA)/Young Adult Longitudinal Trends in Antioxidants (YALTA) Study. Clin Chem. 2007;53:447- 455.
18. Coyne T, Ibiebele TI, Baade PD, et al. Diabetes mellitus and serum carotenoids: findings of a population-based study in Queensland, Australia. Am J Clin Nutr. 2005;82:685-693.
19. Toyod Y, Thomson LR, Langner A, et al. Effect of dietary zeaxan- thin on tissue distribution of zeaxanthin and lutein in quail. Invest Ophthalmol Vis Sci. 2002;43:1210-1221.
20. Kowluru RA. Effect of re-institution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes. 2003;52:818-823.
21. Kowluru RA, Kowluru V, Ho YS, Xiong Y. Overexpression of mitochon- drial superoxide dismutase in mice protects the retina from diabetes- induced oxidative stress. Free Radic Biol Med. 2006;41:1191-1196.
22. Kowluru RA, Kanwar M. Effect of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab (Lond). 2007;4:8.
23. Kowluru RA, Kanwar M, Chang P-S, Glybina I, Iezzi R, Zhang J-P. Micronutrient supplements based on Age-Related Macular Edema Study (AREDS) inhibit abnormalities in retinal metabolism, physiology and early lesions of retinopathy in diabetic rats. Diabetes. In press.
24. Woodall AA, Britton G, Jackson MJ. Carotenoids and protection of phospholipids in solution or in liposomes against oxidation by peroxyl radicals: relationship between carotenoid structure and protective ability. Biochim Biophys Acta. 1997;1336:575-586.
25. Kowluru RA, Engerman RL, Kern TS. Abnormalities of retinal metabolism in diabetes or experimental galactosemia: VIII. Prevention by aminoguanidine. Curr Eye Res. 2000;21:814-819.
26. Kern TS, Tang J, Mizutani M, Kowluru R, Nagraj R, Lorenzi M. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci. 2000;41:3972-3978.
27. Kowluru RA, Atasi L, Ho YS. Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2006;47:1594 -1599.
28. Santocono M, Zurria M, Berrettini M, Fedeli D, Falcioni G. Influence of astaxanthin, zeaxanthin and lutein on DNA damage and repair in UVA-irradiated cells. J Photochem Photobiol B. 2006;85:205-215.
29. Sanz MM, Johnson LE, Ahuja S, Ekstrom PA, Romero J, van Veen T. Significant photoreceptor rescue by treatment with a combination of antioxidants in an animal model for retinal degeneration. Neu- roscience. 2007;145:1120-1129.
30. Kowluru RA, Kern TS, Engerman RL. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antiox- idant defense system. Free Radic Biol Med. 1997;22:587-592.
31. Du Y, Miller CM, Kern TS. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med. 2003; 35:1491-1499.
32. Mustata GT, Rosca M, Biemel KM, et al. Paradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats: improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking. Diabetes. 2005;54:517-526.
33. Trevithick-Sutton CC, Foote CS, Collins M, Trevithick JR. The retinal carotenoids zeaxanthin and lutein scavenge superoxide and hydroxyl radicals: a chemiluminescence and ESR study. Mol Vis. 2006;12:1127-1135.
34. Wrona M, Korytowski W, Rozanowska M, Sarna T, Truscott TG. Cooperation of antioxidants in protection against photosensitized oxidation. Free Radic Biol Med. 2003;35:1319-1329.
35. Zheng L, Du Y, Miller C, et al. Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with strep- tozotocin-induced diabetes. Diabetologia. 2007;50:1987-1996.
36. Radi R, Cassina A, Hodara R, Quijano C, Castro L. Peroxynitrite reactions and formation in mitochondria. Free Radic Biol Med. 2002;33:1451-1464.
37. Virag L, Szabo E, Gregely P, Szabo C. Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Lett. 2003;140-141:113-124.
38. Kowluru RA, Koppolu P, Chakrabarti S, Chen S. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic Res. 2003;37:1169-1180.
39. Scheidegger R, Pande AK, Bounds PL, Koppenol WH. The reaction of peroxynitrite with zeaxanthin. Nitric Oxide. 1998;2:8-16.
40. Panasenko OM, Sharov VS, Briviba K, Sies H. Interaction of per-oxynitrite with carotenoids in human low density lipoproteins. Arch Biochem Biophys. 2006;373:302-305.
41. Obrosova IG, Minchenko AG, Marinescu V, et al. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia. 2001;44:1102-1110.
42. -/- mouse. Paper presented at the ARVO Summer Eye Research Conference, Sanibel Island, FL, July 9-12, 2006.
43. Perez VL. VEGF increases retinal vascular ICAM-1 expression in vivo. Invest Ophthalmol Vis Sci. 1999;40:1808-1812.
44. During A, Dawson HD, Harrison EH. Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibe. J Nutr. 2005;135:2305-2312.
45. Voutilainen S, Nurmi T, Mursu J, Rissanen TH. Carotenoids and cardiovascular health. Am J Clin Nutr. 2006;83:1265-1271.
46. Molnar J, Gyemant N, Mucsi I, et al. Modulation of multidrug resistance and apoptosis ofcancer cells by selected carotenoids. In Vivo. 2004;237-244.
47. Zhang S, Hunter DJ, Rosner BA, et al. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. JNatl Cancer Inst. 1999;91:547-556.